Patents Assigned to NPS Allelix Biopharmaceuticals, Inc.
  • Publication number: 20040167158
    Abstract: Described herein are compounds useful in the treatment of migraine, which have the general formula: 1
    Type: Application
    Filed: February 24, 2004
    Publication date: August 26, 2004
    Applicant: NPS ALLELIX BIOPHARMACEUTICALS, INC.
    Inventors: Louise Edwards, Methvin Isaac, Shawn Maddaford, Abdelmalik Slassi, Tao Xin
  • Patent number: 6716837
    Abstract: Described herein are compounds useful in the treatment of migraine, which have the general formula: wherein: W is a CH group or a N atom; Z is N or C—R4; B and D are selected independently from CH and N, with the proviso that at least one of B and D is CH and with the further proviso that one of B and D can represent N only when W and Z are both other than N; A is a group of Formula II, III or IV, such that group A contains at least 1 N atom; NR7 is either —NH— or —N═; is a single or double bond; X is a N atom, a CH group or a C(OH) group when is a single bond; or, when is a double bond, a C atom; Y is an NH, N-alkyl, N-benzyl or CH2 group; U and V each represent a N atom or a CH group, with the proviso that both cannot be N; a and b are, independently, 0 or 1; c is an integer from 0 to 3; d is an integer from 1 to 3; e is an integer from 1 to 2; f is an integer from 0 to 3; g is an integer from 3 to 6 and h is an integer from 2 to 3; such that the sum of c a
    Type: Grant
    Filed: November 13, 2000
    Date of Patent: April 6, 2004
    Assignee: NPS Allelix Biopharmaceuticals, Inc.
    Inventors: Louise Edwards, Methvin Isaac, Shawn Maddaford, Abdelmalik Slassi, Tao Xin